Risk Factors Determining Chemotherapeutic Toxicity in Patients with Advanced Colorectal Cancer

ISSN： 0114-5916

Source： Drug Safety, Vol.23, Iss.4, 2000-10, pp. : 255-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients

By Cortejoso Lucía López-Fernández Luis A

Pharmacogenomics, Vol. 13, Iss. 10, 2012-07 ,pp. : 1173-1191

Future Medicine

Access to resources Recommend Favorite

Benefit-Risk Assessment of Irinotecan in Advanced Colorectal Cancer

By Glimelius Bengt

Drug Safety, Vol. 28, Iss. 5, 2005-01 ,pp. : 417-433

Adis International

Access to resources Recommend Favorite

Chemotherapeutic Potential of Curcumin for Colorectal Cancer

Current Pharmaceutical Design, Vol. 8, Iss. 19, 2002-09 ,pp. : 1695-1706

Bentham Science Publishers

Access to resources Recommend Favorite

First-Line Treatment Strategies to Improve Survival in Patients with Advanced Colorectal Cancer

By Gill S.

Drugs, Vol. 64, Iss. 1, 2004-01 ,pp. : 27-44

Adis International

Access to resources Recommend Favorite

Elderly patients with advanced colorectal cancer: which therapy is the safest?

By Rosati Gerardo

Expert Opinion on Drug Safety, Vol. 4, Iss. 6, 2005-11 ,pp. : 1041-1049

Informa Healthcare

Access to resources Recommend Favorite